The Fragmented Middle: Why Patient Momentum Breaks After Intake The front door of a patient program can look polished—clean onboarding, clear eligibility screens, and thoughtful brand design. The operational reality is usually messier. For many biopharma operators, momentum starts to flatten as soon as the user leaves initial interest and moves into routing, testing, access, […] The post The Fragmented Middle appeared first on ixlayer .